COVID-19 and New-Onset Diabetes   Listen in as Dr. Irl Hirsch, Professor of Medicine and Diabetes Treatment and Teaching Chair at the University of Washington Medical Center in Seattle, WA., presents on an intriguing topic, that of new-onset diabetes due to COVID-19.   Recorded September 21, 2021.

Listen in as Dr. Vanita Aroda, Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston and faculty at Harvard Medical School, covers the ever-changing landscape and paradigm shifts in the management of patients with type 2 diabetes. Recorded September 14, 2021

Listen in as Dr. Keith Ferdinand, Professor of Medicine and Gerald S. Berenson Endowed Chair in Preventive Cardiology at the Tulane University School of Medicine and the Tulane Heart and Vascular Institute in New Orleans, Louisiana shares his insight on ethnic & racial disparities in cardiometabolic health. Dr. Ferdinand has dedicated his career to improving these disparities, and was more recently named as CMHC's Educational Planning Advisor for Ethnic & Racial Disparities in Cardiometabolic Health.   Recorded Aug 10, 2021

Listen in as Dr. Adam DeVore, cardiologist and Associate Professor of Medicine at Duke University School of Medicine in Durham, North Carolina share results from the CONNECT-HF trial.   Recorded Date July 12, 2021

Dr. Hallberg is a nationally and internationally recognized expert in the field of carbohydrate restriction for type 2 diabetes, and part of the largest and longest trial to date in this field. In this interview Dr. Hallberg discusses the evidence behind ketogenic/low carb diets in reducing cardiometabolic risk and much more.

Listen to CMHC's Senior Planning Committee Member and Spring 2021 Keynote, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss ethnic and racial disparaties among caring for patients with cardiometabolic risk and COVID-19.